ECOG performance status of less than or equal to (</=) 1Xx_NEWLINE_xXECOG performance status 0 or 1Xx_NEWLINE_xXSTEP II: ECOG performance status 0, 1, or 2 (PS 3 allowed if secondary to pain)Xx_NEWLINE_xXECOG performance status =< 2Xx_NEWLINE_xXECOG performance status 0 or 1Xx_NEWLINE_xXPerformance status 0, 1 or 2Xx_NEWLINE_xXPatients with GOG performance status of 3 or 4Xx_NEWLINE_xXECOG performance score 0-3Xx_NEWLINE_xXECOG performance status 0-2Xx_NEWLINE_xXPatients must have an ECOG performance status of 0-2Xx_NEWLINE_xXCRITERIA FOR MAINTENANCE THERAPY-STEP 4: Patients must have an ECOG performance status of 0-3Xx_NEWLINE_xXECOG performance status 0-2Xx_NEWLINE_xXRE-REGISTRATION ELIGIBILITY CRITERIA (STEP 2): ECOG performance status 0-2Xx_NEWLINE_xXPatients with a GOG performance status of 0, 1, or 2Xx_NEWLINE_xXECOG performance status 0-1.Xx_NEWLINE_xXECOG performance status ? 1Xx_NEWLINE_xXECOG performance status <1Xx_NEWLINE_xXECOG Performance Status ? 1.Xx_NEWLINE_xXECOG performance status of 0-1.Xx_NEWLINE_xXWHO performance status of 0 or 1Xx_NEWLINE_xXPerformance Status of 0, 1, or 2Xx_NEWLINE_xXECOG < 2Xx_NEWLINE_xXECOG performance status of 0 or 1Xx_NEWLINE_xX5. ECOG performance status of 0 or 1;Xx_NEWLINE_xXECOG Performance Status of 0-1Xx_NEWLINE_xXECOG Performance Status of 0 or 1Xx_NEWLINE_xXHave a performance status of ? 1 on the ECOG Performance ScaleXx_NEWLINE_xXECOG performance status 0 or 1Xx_NEWLINE_xXECOG performance-status score of 2 or lessXx_NEWLINE_xXPerformance status of 0 or 1Xx_NEWLINE_xXECOG performance status (PS) score 0-1.Xx_NEWLINE_xXECOG performance status score ? 2.Xx_NEWLINE_xXECOG ? 2Xx_NEWLINE_xXECOG performance status of 0 or 1Xx_NEWLINE_xXECOG performance status 0 to 2Xx_NEWLINE_xXECOG Performance Status of 0 or 1Xx_NEWLINE_xXThe ECOG performance status must be 0 or 1.Xx_NEWLINE_xXECOG performance status less than or equal to 3Xx_NEWLINE_xXECOG Performance Status 0-2Xx_NEWLINE_xXECOG Performance Status ? 2Xx_NEWLINE_xXECOG Performance status of 0 or 1Xx_NEWLINE_xXCOHORT 2: ECOG performance status < 2Xx_NEWLINE_xXRANDOMIZED PHASE II CLINICAL TRIAL: ECOG performance status 0-2Xx_NEWLINE_xXMust have an ECOG performance status of 0 - 2, or KPS ? 60.Xx_NEWLINE_xXPatients must have an ECOG Performance Status (PS) ? 1.Xx_NEWLINE_xXPerformance status of 0 or 1Xx_NEWLINE_xXPerformance status 0-1.Xx_NEWLINE_xXECOG performance status of 0 or 1Xx_NEWLINE_xXECOG performance status (PS) ? 1.Xx_NEWLINE_xXECOG performance status of 0-2Xx_NEWLINE_xXECOG performance status Grade 0-2Xx_NEWLINE_xXECOG Performance Status ? 1Xx_NEWLINE_xXECOG ? 1Xx_NEWLINE_xXECOG performance status of 0,1 or 2Xx_NEWLINE_xXPerformance status of Eastern Cooperative Oncology Group (ECOG) 0-2; patients with ECOG of 3 may be allowed to enroll after discussion with the regulatory-sponsor/principal investigator and medical monitor, and if the performance status is believed to be secondary to lymphoma related symptoms and performance status is expected to improve once chemotherapy commencesXx_NEWLINE_xXPatients must be ambulatory and have an ECOG Performance Score of 0 or 1;Xx_NEWLINE_xXENDOCRINE RESISTANT AND ADJUVANT COHORT: ECOG performance status of 0, 1 or 2Xx_NEWLINE_xXPatient with ECOG ? 2Xx_NEWLINE_xXECOG performance status of 0 - 2 and estimated survival of at least 3 monthsXx_NEWLINE_xXECOG performance status 0-1 (appendix I) documented within 90 days prior to randomization.Xx_NEWLINE_xXECOG 0-2Xx_NEWLINE_xXECOG performance status ?2.Xx_NEWLINE_xXECOG performance status of 0, 1, or 2.Xx_NEWLINE_xXHave an ECOG performance status (PS) of ?2.Xx_NEWLINE_xXECOG 0 or 1Xx_NEWLINE_xXECOG performance status (PS) of 0 or 1 a. ECOG PS of 2 may be eligible upon the review and approval of the Medical Monitor.Xx_NEWLINE_xXECOG performance status of 0 or 1Xx_NEWLINE_xXECOG performance status 0 or 1.Xx_NEWLINE_xXSubjects with PS of 0 or 1 on the ECOG Performance ScaleXx_NEWLINE_xXECOG performance status 0 or 1Xx_NEWLINE_xXECOG performance status of 0 or 1 at enrollmentXx_NEWLINE_xXThe ECOG performance status must be 0-1.Xx_NEWLINE_xXECOG performance status of 0, 1, or 2Xx_NEWLINE_xXEXPANDED ACCESS COHORT: ECOG performance status =< 2Xx_NEWLINE_xXECOG performance status 0-1Xx_NEWLINE_xXPatient with an ECOG performance status 0 or 1Xx_NEWLINE_xXAdequate Performance StatusXx_NEWLINE_xXHas an ECOG Performance Status of 0 or 1.Xx_NEWLINE_xXPerformance status =< 2Xx_NEWLINE_xXPerformance Status (PS) ? 2:Xx_NEWLINE_xXECOG 0 or 1Xx_NEWLINE_xXECOG performance status ? 1.Xx_NEWLINE_xXECOG performance status of 0 or 1.Xx_NEWLINE_xXECOG >2 performance status (Appendix A)Xx_NEWLINE_xXARM 2 - A: ECOG performance status =< 3Xx_NEWLINE_xXECOG performance status 0-1Xx_NEWLINE_xXECOG 0-2Xx_NEWLINE_xXECOG Performance Status of ? 2Xx_NEWLINE_xXECOG performance status 0-2.Xx_NEWLINE_xXPatient has a WHO performance status 0-1Xx_NEWLINE_xXECOG Performance status of ? 2Xx_NEWLINE_xXSubjects must have an ECOG performance status of 0-2Xx_NEWLINE_xXAdequate performance status: ECOG ? 2;Xx_NEWLINE_xXPerformance Status: ECOG 0, 1, and 2 (See Appendix III)Xx_NEWLINE_xXECOG Performance status 0-1 within 8 weeks prior to study registration.Xx_NEWLINE_xXECOG performance status less than or equal to 3Xx_NEWLINE_xXECOG performance status of </= 2Xx_NEWLINE_xXECOG performance status of 2 or greaterXx_NEWLINE_xXECOG Performance status of 0 or 1.Xx_NEWLINE_xXPatients must have an ECOG performance status of 0-1Xx_NEWLINE_xXECOG performance status 0-1 (appendix II) assessed within 90 days of randomization.Xx_NEWLINE_xXECOG performance status score of 2 or lessXx_NEWLINE_xXECOG performance status of 0 or 1Xx_NEWLINE_xXPerformance status of 0-3Xx_NEWLINE_xXECOG performance status ? 2. (Patients with lower performance status based solely on bone pain secondary to multiple myeloma may be eligible following consultation and approval of the medical monitor)Xx_NEWLINE_xXMust have ECOG performance status of 0 or 1Xx_NEWLINE_xXPerformance status of 0, 1, or 2Xx_NEWLINE_xXECOG performance status (0-2)Xx_NEWLINE_xXCOHORT 2: TRIPLE NEGATIVE BREAST CANCER: ECOG performance status 0 or 1Xx_NEWLINE_xXCOHORT 3: ENDOMETRIAL CANCER: ECOG performance status 0 or 1Xx_NEWLINE_xXECOG performance status of 2Xx_NEWLINE_xXGood performance statusXx_NEWLINE_xXECOG performance status 0 or 1Xx_NEWLINE_xXParticipant must have an ECOG Performance status:Xx_NEWLINE_xXHave performance status of 0 or 1 on the GOG performance scaleXx_NEWLINE_xXECOG performance status 0-1Xx_NEWLINE_xXParticipants must have an ECOG performance status of less than or equal to 1Xx_NEWLINE_xXHave a performance status of 0 or 1 on the ECOG performance scale.Xx_NEWLINE_xXECOG status <3Xx_NEWLINE_xXHave adequate performance status (ECOG 0-2)Xx_NEWLINE_xXECOG 3 - 4Xx_NEWLINE_xXECOG Performance Status (PS) 0-2;Xx_NEWLINE_xXECOG 0 or 1Xx_NEWLINE_xXECOG performance status ?2Xx_NEWLINE_xXECOG performance status 0-1Xx_NEWLINE_xXECOG performance status of 0, 1 or 2Xx_NEWLINE_xXECOG 0 or 1Xx_NEWLINE_xXECOG performance status of 0, 1 or 2Xx_NEWLINE_xXECOG performance status > 1Xx_NEWLINE_xXECOG Performance Status (PS) 0-1;Xx_NEWLINE_xXPHASE II: ECOG performance status =< 2Xx_NEWLINE_xXPerformance status of 0 to 3Xx_NEWLINE_xXPerformance Status (ECOG) 0-1 at study entry;Xx_NEWLINE_xXECOG of 0 or 1Xx_NEWLINE_xXAn ECOG Performance Status of 0 to 1 and Karnofsky Performance Status of 80 - 100Xx_NEWLINE_xXParticipant must have an ECOG Performance status:Xx_NEWLINE_xXECOG status <3Xx_NEWLINE_xXHave adequate performance status (ECOG 0-2)Xx_NEWLINE_xXPerformance status =< 3Xx_NEWLINE_xXECOG 0-2Xx_NEWLINE_xXECOG performance status of 0 or 1Xx_NEWLINE_xXECOG Performance Status (PS) of 0, 1 or 2. For newly diagnosed AML patients < 75 years of age, ECOG 0-3; for ? 75 years of age, ECOG 0-2.Xx_NEWLINE_xXECOG performance score of 0 or 1 .Xx_NEWLINE_xXPerformance status =< 1Xx_NEWLINE_xXECOG performance status > 2Xx_NEWLINE_xXPerformance status of 0 or 1Xx_NEWLINE_xXECOG performance status 0 or 1.Xx_NEWLINE_xXPatients must exhibit an Eastern Cooperative Oncology Group (ECOG) status of 0-1; ECOG performance status 2 and 3 will be allowed only if decline in performance status is thought to be directly secondary to breast cancer disease burden by treating physicianXx_NEWLINE_xXECOG performance status of 2Xx_NEWLINE_xXPerformance status of 0-3Xx_NEWLINE_xXPHASE II: Patients must have an ECOG performance status of 0-1Xx_NEWLINE_xXECOG performance status ? 2Xx_NEWLINE_xXECOG performance status of 0-2 (dose escalation phase); ECOG performance status of 0-1 (expansion phase).Xx_NEWLINE_xXECOG performance status (PS) 0-2Xx_NEWLINE_xXPerformance status of 0, 1, or 2Xx_NEWLINE_xXPHASE II SCLC: ECOG performance status =< 2Xx_NEWLINE_xXmCRPC EXPANSION COHORT: ECOG performance status =< 2Xx_NEWLINE_xXECOG Performance Status of 0 or 1.Xx_NEWLINE_xXECOG performance status of 0-2 (inclusive)Xx_NEWLINE_xXECOG performance status ? 1Xx_NEWLINE_xXHave a performance status of 0 or 1 on the ECOG Performance Scale.Xx_NEWLINE_xXECOG performance status of < 1 on Day1 Cycle 1Xx_NEWLINE_xXECOG performance status of 0 or 1.Xx_NEWLINE_xXECOG performance status 0-1Xx_NEWLINE_xXECOG performance scale of 0-1Xx_NEWLINE_xXECOG Performance Status of 0-1.Xx_NEWLINE_xXWHO Performance Status 0, 1 or 2. A maximum of 1/3 of patients in cohorts A & B may be WHO performance status 2Xx_NEWLINE_xXECOG performance status (PS) of 0 or 1Xx_NEWLINE_xXECOG >2 performance status (Appendix D)Xx_NEWLINE_xXECOG performance status between 0 and 2Xx_NEWLINE_xXMust have adequate performance status:Xx_NEWLINE_xXECOG Performance Status of 0 or 1Xx_NEWLINE_xXPatients with a GOG Performance Status of 0, 1, or 2.Xx_NEWLINE_xXClinical performance status of ECOG 0-1 within 30 days of signing informed consentXx_NEWLINE_xXECOG performance status of 0 or 1Xx_NEWLINE_xXECOG performance status of ? 2.Xx_NEWLINE_xXECOG performance status ? 1Xx_NEWLINE_xXPerformance status of 0, 1, or 2Xx_NEWLINE_xXECOG performance status of 3Xx_NEWLINE_xXPerformance status ECOG 0-2Xx_NEWLINE_xXECOG status 3 or 4Xx_NEWLINE_xXECOG performance status of 0-2.Xx_NEWLINE_xXECOG performance status ? 2Xx_NEWLINE_xXECOG performance status > 1Xx_NEWLINE_xXThe patient must have an ECOG performance status of 0, 1.Xx_NEWLINE_xXThe ECOG performance status must be greater than or equal to 2.Xx_NEWLINE_xXECOG Performance Status of 0 or 1.Xx_NEWLINE_xXPerformance status =< 2Xx_NEWLINE_xXECOG performance status 0-1Xx_NEWLINE_xXECOG performance status 0-2Xx_NEWLINE_xXFor Phase I and II: ECOG Performance Status </= 2Xx_NEWLINE_xXECOG performance =< 2 at the time of second registrationXx_NEWLINE_xXECOG functional status 0-2Xx_NEWLINE_xXECOG performance status </=2.Xx_NEWLINE_xXClinical performance status of ECOG 0-2 within 14 days of lymphodepletion (Turnstile II)Xx_NEWLINE_xXECOG performance status 0-1.Xx_NEWLINE_xXPerformance status 0-2Xx_NEWLINE_xXHave an ECOG performance status of ? 1Xx_NEWLINE_xXPerformance status >= 60%Xx_NEWLINE_xXPerformance status >= 2Xx_NEWLINE_xXELIGIBILITY CRITERIA FOR REGISTRATION: ECOG performance status =< 2Xx_NEWLINE_xXECOG performance status of 3 or 4Xx_NEWLINE_xXPerformance status will not be consideredXx_NEWLINE_xXECOG performance status of 3 and 4Xx_NEWLINE_xXECOG performance status of ? 2 at study entry (see Appendix A).Xx_NEWLINE_xXPoor performance status (ECOG > 1)Xx_NEWLINE_xXPerformance status =< 3Xx_NEWLINE_xXECOG performance status of 0 or 1Xx_NEWLINE_xXSubject has ECOG performance status 0 to 1.Xx_NEWLINE_xXECOG Performance Status of 0 or 1Xx_NEWLINE_xXThe patient must have an ECOG performance status of 0, 1.Xx_NEWLINE_xXWHO performance status 0-1Xx_NEWLINE_xXThe ECOG performance status must be 0 or 1Xx_NEWLINE_xXECOG Performance Status III or IV;Xx_NEWLINE_xXECOG performance status of ? 2.Xx_NEWLINE_xXECOG ?2.Xx_NEWLINE_xXECOG performance status (PS) ? 1Xx_NEWLINE_xXECOG Performance Status ? 1.Xx_NEWLINE_xXECOG performance status 0- 2Xx_NEWLINE_xXECOG performance status of ?2.Xx_NEWLINE_xXPerformance status ECOG 0-1Xx_NEWLINE_xXECOG performance status 0-1.Xx_NEWLINE_xXHas an ECOG performance status score of 0 to 2.Xx_NEWLINE_xXECOG performance 0, 1 or 2Xx_NEWLINE_xXECOG performance status of 0 or 1 at screening.Xx_NEWLINE_xXAdequate performance status (ECOG 0 or 1). (Appendix 1)Xx_NEWLINE_xXPatient with ECOG ? 2Xx_NEWLINE_xXPerformance status (ECOG PS) 0-2Xx_NEWLINE_xXECOG performance status 0-2.Xx_NEWLINE_xXECOG performance status 0-2 (Appendix 3)Xx_NEWLINE_xXECOG 0,1Xx_NEWLINE_xXECOG performance status 0 to 2Xx_NEWLINE_xXECOG performance status of 0, 1, or 2Xx_NEWLINE_xXECOG performance status (PS) 0 to 2.Xx_NEWLINE_xXECOG performance status ?2.Xx_NEWLINE_xXECOG Performance Status (PS) 0-1;Xx_NEWLINE_xXECOG performance status 0 or 1.Xx_NEWLINE_xXECOG performance status of 0, or 1, or 2Xx_NEWLINE_xXECOG Performance Status 0 - 1Xx_NEWLINE_xXECOG performance status 0 or 1Xx_NEWLINE_xXECOG performance status 0 to 1Xx_NEWLINE_xXECOG performance status of 0/1Xx_NEWLINE_xXECOG performance status of 0-2Xx_NEWLINE_xXECOG performance status within 48 hours prior to induction chemotherapy ? 3Xx_NEWLINE_xXECOG performance status ? 3Xx_NEWLINE_xXAdequate performance status (ECOG 0 or 1) (Appendix 1)Xx_NEWLINE_xXECOG performance status 0 to 2;Xx_NEWLINE_xXREGISTRATION TO TREATMENT (STEP 2): Patients have an ECOG performance status of 0-1Xx_NEWLINE_xXECOG 3 or 4Xx_NEWLINE_xXHave ECOG performance status of 0 or 1Xx_NEWLINE_xXHave an ECOG Performance Status score of 0 to 2.Xx_NEWLINE_xXECOG performance status 0-1Xx_NEWLINE_xXECOG performance status ? 2Xx_NEWLINE_xXPerformance status (ECOG) of 0-2.Xx_NEWLINE_xXECOG performance status of 0 - 1 (Appendix C).Xx_NEWLINE_xXECOG ? 1Xx_NEWLINE_xXECOG performance status (PS) 0-3 (restricted to ECOG PS 0-2 if >= 70 years of age)Xx_NEWLINE_xXPatients must have an ECOG performance status of 0-2Xx_NEWLINE_xXPatients must have an ECOG performance status of 0 -2Xx_NEWLINE_xXARM B: ECOG performance status (PS) 0 or 1Xx_NEWLINE_xXDOSE EXPANSION COHORT: ECOG performance status 0-2Xx_NEWLINE_xXStep 2: ECOG performance status =< 1Xx_NEWLINE_xXECOG performance status 0-2Xx_NEWLINE_xXECOG performance status of 0 to 1Xx_NEWLINE_xXPerformance status 0-1Xx_NEWLINE_xXPerformance status of 0 or 1Xx_NEWLINE_xXPHASE II: Patients must have ECOG performance status of 0 or 1Xx_NEWLINE_xXPatients must have ECOG performance status of < 2.Xx_NEWLINE_xXPatients must have an ECOG performance status of 0, 1 or 2Xx_NEWLINE_xXPHASE II: ECOG performance status 0 or 1Xx_NEWLINE_xXECOG performance status =< 2Xx_NEWLINE_xXECOG performance status of 2, 3, or 4Xx_NEWLINE_xXPatients with GOG performance status of 3 or 4Xx_NEWLINE_xXECOG performance status of 0 or 1Xx_NEWLINE_xXECOG performance status of 0 or 1.Xx_NEWLINE_xXPerformance Status:Xx_NEWLINE_xXCohort A (asymptomatic): ECOG performance status ?1 Cohort B (symptomatic): ECOG performance status ?2Xx_NEWLINE_xXAcceptable ECOG status 0, 1, or 2;Xx_NEWLINE_xXECOG performance status 0, 1 or 2Xx_NEWLINE_xXSubjects must have an ECOG Performance Score of 0-1.Xx_NEWLINE_xXECOG performance status of ? 1.Xx_NEWLINE_xXPerformance status 0-1Xx_NEWLINE_xXECOG Performance Status 0 or 1Xx_NEWLINE_xXECOG Performance status of 0 to 2.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status of 0-2; patients with ECOG performance status of 3 will be eligible if the lower performance status is deemed by the investigator to be due entirely to accelerated or blastic phase MPN and not due to another comorbidityXx_NEWLINE_xXECOG performance status of 0 or 1.Xx_NEWLINE_xXECOG performance status of 0 to 2.Xx_NEWLINE_xXECOG performance status of 0, 1, or 2.Xx_NEWLINE_xXECOG performance status of 0-1 (score of 2 may be acceptable)Xx_NEWLINE_xXECOG performance status of 0-1Xx_NEWLINE_xXECOG performance status of 0-1Xx_NEWLINE_xXECOG performance status of 0-1 (score of 2 may be acceptable)Xx_NEWLINE_xXThe patient has an ECOG performance score (PS) of 0-2.Xx_NEWLINE_xXThe patient has an ECOG performance score (PS) of 0-2.Xx_NEWLINE_xXECOG performance status of 0 to 1Xx_NEWLINE_xXECOG performance status of 0 or 1Xx_NEWLINE_xXPatients must have a GOG performance status of 0 or 1Xx_NEWLINE_xXECOG performance status 0-2.Xx_NEWLINE_xXECOG performance status ? 1Xx_NEWLINE_xXECOG Performance Status <= 1.Xx_NEWLINE_xXECOG performance status ? 2.Xx_NEWLINE_xXHas an ECOG performance status of 0 or 1.Xx_NEWLINE_xXECOG performance status 0-2Xx_NEWLINE_xXPatients with GOG performance status of 2, 3 or 4; or ECOG performance status of 2, 3 or 4Xx_NEWLINE_xXECOG performance status of ? 2.Xx_NEWLINE_xXECOG performance status ?2Xx_NEWLINE_xXMF PATIENTS: Patients must have an ECOG status 0-2Xx_NEWLINE_xXECOG Performance Status score of 0 or 2 for subjects with NMC; 0-1 for subjects with other tumor types.Xx_NEWLINE_xXECOG performance status 0 to 1Xx_NEWLINE_xXECOG status ?1.Xx_NEWLINE_xXECOG performance status of ? 2Xx_NEWLINE_xXECOG performance status (PS) of 0 or 1Xx_NEWLINE_xXPatients must have a GOG performance status of 0 or 1.Xx_NEWLINE_xXECOG performance status ? 2Xx_NEWLINE_xXECOG of 0 to 1Xx_NEWLINE_xXECOG performance status <2Xx_NEWLINE_xXPatients must have an ECOG Performance Status ? 1.Xx_NEWLINE_xXECOG performance status 0 or 1Xx_NEWLINE_xXPatients must have a ECOG performance status of 0 or 1Xx_NEWLINE_xXECOG Performance status of 0 to 1.Xx_NEWLINE_xXPatient has an ECOG performance status ? 2 (Patients with lower performance status based solely on bone pain secondary to multiple myeloma will be eligible)Xx_NEWLINE_xXECOG Performance Status 0-1.Xx_NEWLINE_xXECOG performance status ? 1Xx_NEWLINE_xXECOG Performance Status score of ? 1Xx_NEWLINE_xXECOG Performance Status 0, 1, or 2Xx_NEWLINE_xXECOG Performance Status of ? 2Xx_NEWLINE_xXECOG Performance Status of ? 2.Xx_NEWLINE_xXECOG Performance Status of ? 2Xx_NEWLINE_xXECOG Performance Status of ? 2.Xx_NEWLINE_xXECOG Performance Status of ? 1.Xx_NEWLINE_xXPatients with ECOG performance grade of 3 or 4Xx_NEWLINE_xXECOG ?2.Xx_NEWLINE_xXECOG status of 0 or 1.Xx_NEWLINE_xXECOG Performance Status less than or equal to 2Xx_NEWLINE_xXECOG Performance status 0 or 1Xx_NEWLINE_xXPerformance Status 0-2;Xx_NEWLINE_xXECOG Performance Status score 0 or 1Xx_NEWLINE_xXHave a performance status of 0 or 1 on the ECOG performance scaleXx_NEWLINE_xXECOG Performance Status (PS) score of 0-1.Xx_NEWLINE_xXECOG performance status >2 after optimization of analgesicsXx_NEWLINE_xXECOG performance status of 0 to 1Xx_NEWLINE_xXECOG 0 or 1Xx_NEWLINE_xXHave an ECOG Performance Status 0 or 1 at ScreeningXx_NEWLINE_xXECOG performance status of 0 or 1Xx_NEWLINE_xXECOG performance status ?1Xx_NEWLINE_xXHave a performance status of 0 or 1 on the ECOG Performance Scale.Xx_NEWLINE_xXECOG performance status of 0 or 1 (see Error! Reference source not found.).Xx_NEWLINE_xXPerformance Status 0-1Xx_NEWLINE_xXPerformance status must be 0-1.Xx_NEWLINE_xXECOG performance status ? 1Xx_NEWLINE_xXHas ECOG performance status 0 or 1 on Cycle 1, Day 1Xx_NEWLINE_xXECOG performance status 0-2Xx_NEWLINE_xXECOG performance status of 0-1Xx_NEWLINE_xXECOG performance status </= 2Xx_NEWLINE_xXECOG performance status 0 or 1Xx_NEWLINE_xXECOG performance status between 0-2Xx_NEWLINE_xXPatients with any performance status are eligible for enrollmentXx_NEWLINE_xXPatients must have an ECOG performance status of 0-1Xx_NEWLINE_xX(ECOG) performance status of 0-2Xx_NEWLINE_xXECOG ? 2Xx_NEWLINE_xXECOG performance status ? 3;Xx_NEWLINE_xXECOG Performance Status of 0 or 1 at ScreeningXx_NEWLINE_xXWHO performance status of 3 or 4Xx_NEWLINE_xXECOG Performance Status ? 2Xx_NEWLINE_xXECOG performance status of 0-2.Xx_NEWLINE_xXECOG Performance Status: 0-1Xx_NEWLINE_xXECOG Performance Status 0 or 1.Xx_NEWLINE_xXECOG performance status of 0 or 1.Xx_NEWLINE_xX-  Subject has an ECOG performance status ? 1 at Screening and on Day 1.Xx_NEWLINE_xXECOG performance status of 0-2.Xx_NEWLINE_xXECOG performance status of 0 or 1Xx_NEWLINE_xXPerformance status 0 or 1Xx_NEWLINE_xXECOG performance status of 0 or 1Xx_NEWLINE_xXPatients who have received two or three prior regimens must have an ECOG performance status of 0 or 1Xx_NEWLINE_xXECOG performance status of 0 or 1.Xx_NEWLINE_xXECOG 0 or 1Xx_NEWLINE_xXECOG performance status of 0 to 1Xx_NEWLINE_xXPatients must have an ECOG performance score between 0 and 1.Xx_NEWLINE_xXHave a performance status of 0 or 1 on the ECOG Performance Scale within 14 days prior to registration.Xx_NEWLINE_xXECOG performance status ? 1Xx_NEWLINE_xXECOG performance status of 0 or 1Xx_NEWLINE_xXPatients must have an ECOG Performance Score of 0 or 1.Xx_NEWLINE_xXECOG performance status of 0-2, Karnofsky Performance Status ?60 (for glioma subjects).Xx_NEWLINE_xXWHO/ECOG performance status of 0 or 1;Xx_NEWLINE_xXECOG Performance Status of 2 - 3;Xx_NEWLINE_xXDONOR: ECOG performance status 0 or 1Xx_NEWLINE_xXECOG performance status > 3Xx_NEWLINE_xXECOG performance status =< 2, unless the decline of the performance status is considered to be related to CLL symptomsXx_NEWLINE_xXECOG performance status of 0-2Xx_NEWLINE_xXWHO/ECOG performance status of 0 or 1Xx_NEWLINE_xXECOG performance status of 0 to 2.Xx_NEWLINE_xXSubject must have an ECOG performance status of 0 or 1.Xx_NEWLINE_xXHave a performance status ?1 on the ECOG scaleXx_NEWLINE_xXECOG 0 to 2Xx_NEWLINE_xXECOG performance status of 0 - 1.Xx_NEWLINE_xXGOG performance status 0-2;Xx_NEWLINE_xXECOG performance status between 0-2Xx_NEWLINE_xXPHASE II: ECOG performance status =< 1Xx_NEWLINE_xXECOG performance status of 0 - 1Xx_NEWLINE_xXECOG performance status of ? 2.Xx_NEWLINE_xXECOG performance status of ) to 1Xx_NEWLINE_xXECOG performance status 0-1.Xx_NEWLINE_xXECOG performance score ? 1Xx_NEWLINE_xXECOG performance status >= 2Xx_NEWLINE_xXECOG performance status of 0-2.Xx_NEWLINE_xXECOG Performance Status of 0 or 1.Xx_NEWLINE_xXECOG Performance Status of 0 or 1Xx_NEWLINE_xXECOG Performance status 0-1Xx_NEWLINE_xXECOG performance status 0 or 1.Xx_NEWLINE_xXECOG performance status ?2Xx_NEWLINE_xXECOG performance status of 0-2.Xx_NEWLINE_xXECOG performance status of 0 or 1Xx_NEWLINE_xXECOG performance status < 2Xx_NEWLINE_xXECOG performance status of 0 or 1Xx_NEWLINE_xXECOG performance status < 2Xx_NEWLINE_xXECOG Performance Status (PS) </= 2Xx_NEWLINE_xXREGISTRATION INCLUSION CRITERIA: ECOG performance status =< 1Xx_NEWLINE_xXECOG status of >= 2Xx_NEWLINE_xXWHO performance status 0-2Xx_NEWLINE_xXECOG performance status ? 2Xx_NEWLINE_xXECOG performance status (PS) 0-2;Xx_NEWLINE_xXECOG Performance Status of 0, 1 or 2.Xx_NEWLINE_xXECOG Performance Status of 0, 1, or 2Xx_NEWLINE_xXECOG performance status of < 3.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status =< 2; patients with ECOG performance status of 3 (defined as being capable of only limited self-care, confined to bed or chair more than 50% of waking hours) will also be eligible only if the lower performance status is judged to be directly related to steroid and/or cGVHD effectsXx_NEWLINE_xXECOG performance status of 0, 1, or 2Xx_NEWLINE_xXPerformance status >= 60%Xx_NEWLINE_xXECOG performance status of 0-1.Xx_NEWLINE_xXECOG Performance Status 0 or 1.Xx_NEWLINE_xXECOG performance status of 0 or 1Xx_NEWLINE_xXThe patient has an ECOG performance status of 0, 1, or 2Xx_NEWLINE_xXECOG performance status ? 1Xx_NEWLINE_xXECOG Performance Status: 0-2Xx_NEWLINE_xXECOG performance status 0-2 (all cohorts)Xx_NEWLINE_xXPerformance status 0-1Xx_NEWLINE_xXPatients must have an ECOG performance status of =< 2Xx_NEWLINE_xXECOG performance status of < = 2 at study entry.Xx_NEWLINE_xXWHO performance status of ? 1Xx_NEWLINE_xXECOG Performance Status of ? 3Xx_NEWLINE_xXPre-study ECOG performance status 0-2. Patients with lower performance status based solely on bone pain will be eligible.Xx_NEWLINE_xXPerformance status of 0, 1, or 2Xx_NEWLINE_xXECOG performance status ? 1 Patients must have normal organ and marrow function as defined below:Xx_NEWLINE_xXECOG performance status of 0 or 1.Xx_NEWLINE_xXECOG Performance Score of 0 or 1Xx_NEWLINE_xXECOG Performance Status of </= 2Xx_NEWLINE_xXECOG performance status 0-1Xx_NEWLINE_xXECOG performance status 0 to 1Xx_NEWLINE_xXPatients must have a GOG performance status of 0 or 1Xx_NEWLINE_xXHave an ECOG Performance of 0-2Xx_NEWLINE_xXECOG performance status ? 1Xx_NEWLINE_xXAn ECOG performance status of 2Xx_NEWLINE_xXECOG performance status ? 2Xx_NEWLINE_xXECOG Performance Status of 0 or 1Xx_NEWLINE_xXECOG performance status 0 to 1;Xx_NEWLINE_xXECOG performance status score of 0-2.Xx_NEWLINE_xXECOG Performance Status < 1Xx_NEWLINE_xXECOG of 0 or 1Xx_NEWLINE_xXPatients with an ECOG Performance Status of 0, 1, or 2.Xx_NEWLINE_xXPatients with ECOG Performance Grade of 3 or 4Xx_NEWLINE_xXECOG Performance Status of 0, 1, or 2Xx_NEWLINE_xXECOG performance status (PS) 0-1.Pediatric patients with Lansky or Karnofsky Performance Status Scale ? of 50%.Xx_NEWLINE_xXECOG performance status 0-1Xx_NEWLINE_xXECOG performance status 0 or 1Xx_NEWLINE_xXECOG performance status > 2Xx_NEWLINE_xXECOG performance status of 0-3Xx_NEWLINE_xXMust have an ECOG performance status score of less than or equal to 2.Xx_NEWLINE_xXECOG Performance Status of 0 or 1.Xx_NEWLINE_xXECOG Performance Status (PS) of 0-1Xx_NEWLINE_xXECOG performance status less than or equal to 2Xx_NEWLINE_xXECOG of 0 or 1.Xx_NEWLINE_xXParticipant must have an ECOG performance status score of 0 or 1Xx_NEWLINE_xXECOG Performance Status of 0 or 1Xx_NEWLINE_xXECOG performance status of 0 to 1Xx_NEWLINE_xXECOG performance status 0-1Xx_NEWLINE_xXECOG performance status of 0 or 1, measured at screening and immediately before the start of treatment.Xx_NEWLINE_xXAdequate performance status.Xx_NEWLINE_xXAmbulatory with ECOG performance status of 0 or 1Xx_NEWLINE_xXECOG Performance Status of 0-1Xx_NEWLINE_xXECOG performance status of 0 or 1 (see Appendix 8)Xx_NEWLINE_xXECOG performance status of ? 1Xx_NEWLINE_xXECOG Performance Status 0 to 2Xx_NEWLINE_xXECOG performance status of 0 or 1.Xx_NEWLINE_xXECOG performance status of 0 or 1.Xx_NEWLINE_xXECOG performance status 0-1Xx_NEWLINE_xXECOG performance status 0 or 1Xx_NEWLINE_xXECOG performance status of 0-1.Xx_NEWLINE_xXAdequate performance status, defined as:Xx_NEWLINE_xXPerformance status:Xx_NEWLINE_xXECOG performance status ? 2Xx_NEWLINE_xXECOG performance status of 0 or 1Xx_NEWLINE_xXECOG Performance Status ? 2.Xx_NEWLINE_xXPerformance status of 0, 1 or 2 by the ECOG scaleXx_NEWLINE_xXECOG status of ? 2Xx_NEWLINE_xXPerformance Status of 0 or 1Xx_NEWLINE_xXECOG performance status =< 2Xx_NEWLINE_xXECOG Performance status 0-1 (Appendix B)Xx_NEWLINE_xX(ECOG) Performance Status of 0, 1 or 2Xx_NEWLINE_xXPerformance Status of 0 or 1.Xx_NEWLINE_xXECOG Performance Status 0-1Xx_NEWLINE_xXECOG performance status ? 2.Xx_NEWLINE_xXECOG performance status of 0 - 1.Xx_NEWLINE_xXECOG Performance Status ? 1Xx_NEWLINE_xXECOG performance status of 0-2.Xx_NEWLINE_xXWHO performance status of 0-1Xx_NEWLINE_xXECOG performance status of 0 to 1Xx_NEWLINE_xXPatients must have an ECOG performance status of 0, 1, or 2.Xx_NEWLINE_xXTREATMENT: Patients must have an ECOG performance status of 0-2Xx_NEWLINE_xXECOG Performance Status 0 - 1Xx_NEWLINE_xXHave a performance status of 0 or 1 on the ECOG.Xx_NEWLINE_xXECOG Performance Status 0-2Xx_NEWLINE_xXECOG performance status 0-2.Xx_NEWLINE_xXECOG performance status of 0 or 1Xx_NEWLINE_xXECOG ? 2.Xx_NEWLINE_xXHave an ECOG Performance Status of ? 1. Refer to Appendix 1.Xx_NEWLINE_xXECOG performance status of 0 or 1Xx_NEWLINE_xXECOG Performance Score of 0 -2Xx_NEWLINE_xXECOG performance status of 0 to 2Xx_NEWLINE_xXECOG performance status of 0 or 1Xx_NEWLINE_xXECOG performance status of 0 or 1Xx_NEWLINE_xXECOG performance status of 0 or 1Xx_NEWLINE_xXECOG 0-1Xx_NEWLINE_xXECOG performance status 0-2, inclusiveXx_NEWLINE_xXECOG performance status ? 2Xx_NEWLINE_xXECOG Performance Status score of 0, 1 or 2Xx_NEWLINE_xXECOG performance status ? 2Xx_NEWLINE_xXECOG Performance Status of ? 1Xx_NEWLINE_xXPerformance status of 0 to 1 on the ECOG ScaleXx_NEWLINE_xXECOG performed status of 0 or 1Xx_NEWLINE_xXECOG Performance Status of 0 - 2.Xx_NEWLINE_xXECOG Performance Status 0-1.Xx_NEWLINE_xXECOG performance status 0 or 1.Xx_NEWLINE_xXPerformance Status of 0 or 1Xx_NEWLINE_xXECOG performance status of 0 or 1 (see Appendix C)Xx_NEWLINE_xXECOG Performance Status range of 0-2Xx_NEWLINE_xXECOG performance status score 0, 1 or 2Xx_NEWLINE_xXECOG performance status of 0 or 1Xx_NEWLINE_xXECOG performance status 0-2.Xx_NEWLINE_xXECOG performance status 0 or 1Xx_NEWLINE_xXECOG performance status of ?2Xx_NEWLINE_xXECOG 0 or 1Xx_NEWLINE_xXECOG performance status <3Xx_NEWLINE_xXECOG performance status of 0 - 2. -Xx_NEWLINE_xXECOG performance status of ?2Xx_NEWLINE_xXPatients must have an ECOG performance score of 0, 1, or 2.Xx_NEWLINE_xXECOG performance status of 0 or 1Xx_NEWLINE_xXWHO performance status of ? 2.Xx_NEWLINE_xXLow Performance Status (ECOG > 2; Appendix E).Xx_NEWLINE_xXPerformance Status of 0 or 1Xx_NEWLINE_xXECOG performance status 0-2Xx_NEWLINE_xXECOG Performance Status 0 or 1.Xx_NEWLINE_xXECOG performance status > 2.Xx_NEWLINE_xXECOG performance status status >/= 2Xx_NEWLINE_xXECOG Performance Score of 0 or 1Xx_NEWLINE_xXPerformance Status corresponding to ECOG score of 0, 1, or 2:Xx_NEWLINE_xXECOG performance status ?2.Xx_NEWLINE_xXECOG performance status of 0 - 1.Xx_NEWLINE_xXECOG performance status ? 1Xx_NEWLINE_xXECOG performance status of 0 to 1Xx_NEWLINE_xXECOG Performance Status of 0 or 1Xx_NEWLINE_xXECOG performance status of 0, 1 or 2Xx_NEWLINE_xXECOG Performance Status less than or equal to 2Xx_NEWLINE_xXECOG ? 2Xx_NEWLINE_xXECOG 0, 1 or 2Xx_NEWLINE_xXECOG performance status 0-2Xx_NEWLINE_xXECOG performance status ?2Xx_NEWLINE_xXPatients must have ECOG performance status of 0-2Xx_NEWLINE_xXECOG of 0 or 1Xx_NEWLINE_xXDonor must have an ECOG performance status of 0 or 1.Xx_NEWLINE_xXRecipient must have an ECOG performance status of 0 or 1.Xx_NEWLINE_xXECOG performance status of 0, 1, or 2.Xx_NEWLINE_xXECOG Performance Status score of 0 or 1Xx_NEWLINE_xXECOG performance status less than or equal to 2Xx_NEWLINE_xXECOG Performance Status ? 1.Xx_NEWLINE_xXECOG Performance Status ? 1.Xx_NEWLINE_xXECOG Performance Status of 0, 1, or 2.Xx_NEWLINE_xXPerformance status of less than or equal to 2 on ECOG scale.Xx_NEWLINE_xXPatients must have an ECOG performance status of 0 - 1Xx_NEWLINE_xXECOG Performance Status of 0, 1, or 2.Xx_NEWLINE_xXECOG performance status 0-2.Xx_NEWLINE_xXECOG Performance Status of 0, 1 or 2Xx_NEWLINE_xXECOG performance status ? 1Xx_NEWLINE_xXECOG performance status of either 0 or 1Xx_NEWLINE_xXECOG Performance Status 0-2;Xx_NEWLINE_xXECOG Performance Status 0-2Xx_NEWLINE_xXECOG performance score of 0-2.Xx_NEWLINE_xXWHO performance status 0-1.Xx_NEWLINE_xXECOG performance status of 0, 1, or 2Xx_NEWLINE_xXECOG Performance Status ? 2Xx_NEWLINE_xXECOG Performance Status 0 or 1Xx_NEWLINE_xXECOG performance status =< 2Xx_NEWLINE_xXECOG performance status =< 2Xx_NEWLINE_xXPerformance status 0-2Xx_NEWLINE_xXHas an ECOG performance status of 0 or 1Xx_NEWLINE_xXECOG > 2Xx_NEWLINE_xXHave an ECOG performance status of 0 to 1.Xx_NEWLINE_xXSubject has an ECOG Performance Status 0-1.Xx_NEWLINE_xXECOG Performance Status ? 2.Xx_NEWLINE_xXECOG performance status > 2Xx_NEWLINE_xXECOG performance status < 3Xx_NEWLINE_xXPatients with a GOG Performance Status of 0, 1, or 2Xx_NEWLINE_xXAcceptable level of performance status (both)Xx_NEWLINE_xXPerformance status of 2 or betterXx_NEWLINE_xXHave ECOG performance status 0-1Xx_NEWLINE_xXPatients with an ECOG performance status of 0, 1, or 2, and estimated survival of > 12 weeks.Xx_NEWLINE_xXPerformance status of 0 - 1Xx_NEWLINE_xXECOG performance status of 0 or 1Xx_NEWLINE_xXECOG performance status 3 or worseXx_NEWLINE_xXECOG Performance Status (PS) 0 or 1Xx_NEWLINE_xXPatients must have a performance status of 0-2Xx_NEWLINE_xXCONTROL (HEALTHY) GROUP: ECOG performance status 0-1Xx_NEWLINE_xXECOG performance status =< 2Xx_NEWLINE_xXPatients must have an ECOG Performance Status of < 2Xx_NEWLINE_xXECOG performance status of 0 or 1Xx_NEWLINE_xXECOG performance status ?2.Xx_NEWLINE_xXPerformance status =< 1Xx_NEWLINE_xXECOG performance status > 3Xx_NEWLINE_xXECOG Performance status ? 2Xx_NEWLINE_xXPatients must have a good performance status (ECOG<2)Xx_NEWLINE_xXGOG performance status > 2Xx_NEWLINE_xXECOG performance status of 0 or 1Xx_NEWLINE_xXECOG performance status ?2Xx_NEWLINE_xXECOG performance status of 0 to 2Xx_NEWLINE_xXECOG performance status of 0, 1 or 2 at the time of enrollment.Xx_NEWLINE_xXECOG status > 3Xx_NEWLINE_xXECOG performance status > 3Xx_NEWLINE_xXECOG performance status 0 or 1Xx_NEWLINE_xXECOG performance status of ? 1Xx_NEWLINE_xXGeneral performance status evaluated by ECOG 0-2 scale.Xx_NEWLINE_xXPerformance status 0 or 1Xx_NEWLINE_xXSubject has an ECOG performance status 0 to 2.Xx_NEWLINE_xXHas an ECOG performance status of Grade 0 to 2Xx_NEWLINE_xXKarnofsky Performance Status Scale of 60 or higher OR an ECOG Performance Status of 0-2.Xx_NEWLINE_xXECOG performance status of 0 to 2 (Appendix C)Xx_NEWLINE_xXECOG performance status of 0 or 1Xx_NEWLINE_xXNORMAL VOLUNTEERS: Have a ECOG performance status of 0-2Xx_NEWLINE_xXThe patient has ECOG performance status > 1Xx_NEWLINE_xXECOG performance status of 0-2 (or a Karnofsky performance status of >50%)Xx_NEWLINE_xXperformance status of 0 or 1Xx_NEWLINE_xXECOG performance status of 0 to 1.Xx_NEWLINE_xXECOG performance status of 0 or 1.Xx_NEWLINE_xXECOG 0, 1, or 2Xx_NEWLINE_xXECOG performance status of 0 or 1Xx_NEWLINE_xXECOG performance status of 0-2Xx_NEWLINE_xXEastern ECOG performance status of 0 to 2.Xx_NEWLINE_xXSubjects with ECOG performance status of 0 or 1.Xx_NEWLINE_xXECOG performance status of 0-2.Xx_NEWLINE_xXSubjects with ECOG performance status of 0 or 1.Xx_NEWLINE_xXECOG performance status 0-2Xx_NEWLINE_xXECOG performance status >1.Xx_NEWLINE_xXECOG performance status must be 0 or 1Xx_NEWLINE_xXPerformance status as per protocolXx_NEWLINE_xXECOG performance status 0-2Xx_NEWLINE_xXECOG performance status ? 1Xx_NEWLINE_xXECOG performance status greater than or equal to 2Xx_NEWLINE_xX